1. Home
  2. THO vs GKOS Comparison

THO vs GKOS Comparison

Compare THO & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Thor Industries Inc.

THO

Thor Industries Inc.

N/A

Current Price

$115.67

Market Cap

5.3B

Sector

Industrials

ML Signal

N/A

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$121.00

Market Cap

6.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
THO
GKOS
Founded
1980
1998
Country
US
US
Employees
N/A
N/A
Industry
Homebuilding
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
6.3B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
THO
GKOS
Price
$115.67
$121.00
Analyst Decision
Buy
Strong Buy
Analyst Count
10
14
Target Price
$113.75
$133.07
AVG Volume (30 Days)
402.8K
770.3K
Earning Date
03-04-2026
05-14-2026
Dividend Yield
1.80%
N/A
EPS Growth
N/A
0.36
EPS
0.41
N/A
Revenue
$9,579,490,000.00
$383,481,000.00
Revenue This Year
$1.72
$23.29
Revenue Next Year
$5.14
$27.74
P/E Ratio
$21.88
N/A
Revenue Growth
N/A
21.85
52 Week Low
$63.16
$73.16
52 Week High
$122.83
$142.50

Technical Indicators

Market Signals
Indicator
THO
GKOS
Relative Strength Index (RSI) 47.73 54.38
Support Level $112.14 $103.55
Resistance Level $117.14 $121.70
Average True Range (ATR) 3.90 5.58
MACD -0.78 -0.11
Stochastic Oscillator 25.14 72.81

Price Performance

Historical Comparison
THO
GKOS

About THO Thor Industries Inc.

Based in Elkhart, Indiana, Thor Industries manufactures Class A, Class B, and Class C motor homes along with travel trailers and fifth-wheel towables across about 35 brands. Through the acquisition of Erwin Hymer in 2019, the company expanded its geographic footprint and now produces various motorized and towable recreational vehicles for Europe, including motor caravans, camper vans, urban vehicles, caravans, and other RV-related products and services. The company has also begun generating revenue through aftermarket component parts via the acquisition of Airxcel in 2021; however, this is still a nascent part of the business as it accounts for less than 10% of fiscal 2025 total sales. In fiscal 2025, the company wholesaled 181,388 units and generated $9.6 billion in revenue.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: